Author

Vasko Kramer

ORCID 0000-0002-5285-6447Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:imaging· 2 Approach:statistical model· 2 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Adrian Ocampo· 1 shared Analía Cuiza· 1 shared Andrea Calleja· 1 shared Bernd NeumaieriD· 1 shared Boris D. ZlatopolskiyiD· 1 shared Boris Rebolledo‐JaramilloiD· 1 shared Carlos F. HernándeziD· 1 shared Carlos Juri CiD· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Adrian Ocampo

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Preliminary First-in-Human Pharmacokinetic Evaluation, Dosimetry and Safety of 7--Fluorotryptophan as PET Imaging Agent to Visualize Serotonin Synthesis in the Brain

Sophie Stotz, Rodrigo Moraga‐Amaro, Boris D. Zlatopolskiy, Michael Gemki, Gitte M. Knudsen, Bernd Neumaier, Cristian Soza‐Ried, Horacio Amaral P, Vasko Kramer, Matthias M. Herth

This study evaluates the safety, dosimetry, and pharmacokinetics of 7-[18F]Fluorotryptophan as a PET tracer for visualizing serotonin synthesis in the brain.

bioRxiv · Aug 26, 2025 · PreprintNeuroscience

Prodromal manifestations of Parkinson's disease in adults with 22q11.2 microdeletion syndrome

Carlos Juri C, Pedro Chaná‐Cuevas, Vasko Kramer, Rosemarie Fritsch M, Claudia Ornstein, Analía Cuiza, Carlos F. Hernández, Katiuska Villanueva, T. Córdova, Jorge Mauro, Adrian Ocampo, Boris Rebolledo‐Jaramillo, Gonzalo Encina, Andrea Calleja, Javiera Dinator, , Gabriela M. Repetto

This study identifies prodromal Parkinson's disease features in adults with 22q11.2 microdeletion syndrome, showing signs like hyposmia and dysautonomia, with some evidence of dopaminergic signaling changes.

medRxiv · May 18, 2022 · PreprintGenetic & Genomic Medicine